Bioorganic and Medicinal Chemistry Letters p. 589 - 594 (1999)
Update date:2022-08-04
Topics:
Vuligonda, Vidyasagar
Garst, Michael E.
Chandraratna, Roshantha A.S.
Retinoid X Receptor (RXR) specific ligands are currently being investigated for the treatment of metabolic diseases such as type II diabetes. We report the synthesis of conformationally locked retinoids, which are potent RXR selective ligands, and the att
View MoreZhengzhou Minzhong Pharmaceutical Co.,ltd
Contact:0086-371-65797115
Address:15/F,Jiangshan Bldg, NO.126 Huanghe Road,Zhengzhou, China
Shanghai Yuanye Bio-Technology Co., Ltd.
website:http://www.shyuanye.com
Contact:+86-21-61845781
Address:Building 6, No. 465, Changta Road,Songjiang District,Shanghai,China
Contact:0086-22-23410962
Address:17-201, Ningfuli, Shuishanggongyuandong road,Nankai district, Tianjin, China
LinHai Cina Chemical Co., LTD.
Contact:0576-85580989
Address:Pharma-chem zone,Duqiao,Linhai,Zhejiang,China
Zhejiang Tianyu Pharmaceutical Co., Ltd.
Contact:+86-576-84177669, 89189665,89189688,84168770
Address:Jiangkou Development Zone, Huangyan, Taizhou City, Zhejiang
Doi:10.1039/a608360i
(1997)Doi:10.1021/ja980937o
(1998)Doi:10.1016/S0040-4039(01)00357-4
(2001)Doi:10.1248/cpb.49.501
(2001)Doi:10.1021/ma030046n
(2003)Doi:10.1021/jo00977a027
(1972)
